Page 2 of 3
Vernalis plc (LSE: VER) today announces its audited financial results for the year ended 30 June 2017, following the year-end trading update published on 18 July 2017.
More information on Vernalis and its pipeline ...
Company fact sheet
Explore the pipeline ...
T: 0118 938 0000 F: 0118 938 0001Contact informationMaps and directionsContact form
To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and email@example.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch